Article Details

Piper Jaffray Initiates “Hold” Rating for Acorda Therapeutics (NASDAQ:ACOR) With a $22.0 Price ...

Retrieved on: 2018-03-09 05:11:15

Tags for this article:

Click the tags to see associated articles and topics

Piper Jaffray Initiates “Hold” Rating for Acorda Therapeutics (NASDAQ:ACOR) With a $22.0 Price .... View article details on hiswai:

Excerpt

<div><b>Leucadia National Corporation</b> reported 0.03% in Acorda Therapeutics, Inc. (NASDAQ:ACOR). Ubs Asset Mgmt Americas reported 0% stake. California-based Partner Fund Lp has invested 1.88% in Acorda Therapeutics, Inc. (NASDAQ:ACOR). New York State Teachers Retirement Sys holds 0% or ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up